PulteGroup Inc. (PHM)

28.09
NYSE : Consumer Durables
Prev Close 28.05
Day Low/High 27.89 / 28.28
52 Wk Low/High 24.86 / 35.21
Avg Volume 4.38M
Exchange NYSE
Shares Outstanding 284.02M
Market Cap 7.97B
EPS 1.40
P/E Ratio 10.96
Div & Yield 0.36 (1.30%)

Latest News

The U.S. Food And Drug Administration (FDA) Has Granted Orphan Drug Designation To PharmaMar's Lurbinectedin

The U.S. Food And Drug Administration (FDA) Has Granted Orphan Drug Designation To PharmaMar's Lurbinectedin

MADRID, August 3, 2018 /PRNewswire/ -- The U.S.

PharmaMar Announces That The ATLANTIS Study Has Reached The Goal Of Patient Recruitment

PharmaMar Announces That The ATLANTIS Study Has Reached The Goal Of Patient Recruitment

MADRID, July 31, 2018 /PRNewswire/ -- ATLANTIS study, in small-cell lung cancer with lurbinectedin, recruited 600 patients in a total of 160 hospital centers in 20 countries   Top line data is expected to readout around the end of 2019    PharmaMar (MCE:...

PharmaMar Reaches An Agreement With Impilo Pharma, A Part Of Immedica Group, For The Promotion And Distribution Of Yondelis® In The Nordic Countries And Eastern Europe

PharmaMar Reaches An Agreement With Impilo Pharma, A Part Of Immedica Group, For The Promotion And Distribution Of Yondelis® In The Nordic Countries And Eastern Europe

MADRID, July 27, 2018 /PRNewswire/ -- PharmaMar will receive an up-front payment of 2 million euros This agreement  will replace  the  current  agreement  between  PharmaMar  and  Swedish Orphan  Biovitrum  International PharmaMar (MCE: PHM) has announced...

PulteGroup Reports Second Quarter 2018 Financial Results

PulteGroup Reports Second Quarter 2018 Financial Results

PulteGroup, Inc. (NYSE: PHM) announced today financial results for its second quarter ended June 30, 2018.

Housing Stocks Tank on Disappointing New-Home Sales

Housing Stocks Tank on Disappointing New-Home Sales

Home stocks fall after data show single-family home sales slipped in June.

Novice Trade: PulteGroup

Novice Trade: PulteGroup

The tactic is the bullishly biased, near-the-money long call "shooter" expiring in August.

PulteGroup's Built To Honor™ Program Announces Newest Partnership With Operation Homefront

PulteGroup's Built To Honor™ Program Announces Newest Partnership With Operation Homefront

PulteGroup, Inc. (NYSE: PHM) announced today a partnership with Operation Homefront, a national nonprofit organization whose mission is to build strong, stable, and secure military families.

Analyst Favorites With Strong Buyback Activity: PulteGroup Ranks As A Top Pick

Analyst Favorites With Strong Buyback Activity: PulteGroup Ranks As A Top Pick

A study of analyst recommendations at the major brokerages shows that PulteGroup Inc is the #39 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

PulteGroup's Second Quarter 2018 Earnings Conference Call To Begin At 8:00 A.M. On July 26, 2018

PulteGroup's Second Quarter 2018 Earnings Conference Call To Begin At 8:00 A.M. On July 26, 2018

PulteGroup, Inc. (NYSE: PHM) today announced that the start time for the Company's conference call to discuss second quarter 2018 financial results has been changed to 8:00 a.

PulteGroup's Second Quarter 2018 Earnings Release And Webcast Conference Call Scheduled For July 26, 2018

PulteGroup's Second Quarter 2018 Earnings Release And Webcast Conference Call Scheduled For July 26, 2018

PulteGroup, Inc. (NYSE: PHM) today announced that it will release its second quarter 2018 financial results before the market opens on Thursday, July 26, 2018.

PharmaMar And Chugai Agree To Terms For Early Termination Of The License Agreement For Zepsyre® In Japan

PharmaMar And Chugai Agree To Terms For Early Termination Of The License Agreement For Zepsyre® In Japan

MADRID, June 26, 2018 /PRNewswire/ -- PharmaMar regains all its rights for Zepsyre ® in Japan with immediate effec t and receives a payment of € 3,000, 000 from Chugai  PharmaMar progresses in the clinical development of Zepsyre ® in Japan while its...

Life Tested, Now Connected

Life Tested, Now Connected

Enviable design, quality construction, desirable locations and ample choices are why homeowners for decades have chosen to build their dream home with PulteGroup.

PulteGroup Has Broken Out on the Upside

PulteGroup Has Broken Out on the Upside

Charts suggest shares of home builder are headed higher.

PharmaMar Signs A Commercialization And Distribution License Agreement For Aplidin® With Pint Pharma International

PharmaMar Signs A Commercialization And Distribution License Agreement For Aplidin® With Pint Pharma International

MADRID, June 11, 2018 /PRNewswire/ -- PharmaMar (MCE: PHM) has announced today the signing of a commercialization and distribution license agreement with Pint Pharma International, S.

Del Webb Announces Grand Opening Of Highly-Anticipated Rancho Mirage Community (Photo: Business Wire)

Del Webb Announces Grand Opening Of Highly-Anticipated Rancho Mirage Community (Photo: Business Wire)

Del Webb, the nation's leading builder of active adult communities, has scheduled the grand opening of its Rancho Mirage community for June 9, 2018.

PharmaMar Presents In Oral Session At ASCO: The ADMYRE Study's Adjusted Overall Survival With Plitidepsin

PharmaMar Presents In Oral Session At ASCO: The ADMYRE Study's Adjusted Overall Survival With Plitidepsin

MADRID, June 5, 2018 /PRNewswire/ -- Abstract #8018  The modelled data on overall survival of the statistical evaluation of the impact of crossover on the ADMYRE study were presented .

PharmaMar Presents New Results With Lurbinectedin As A Single Agent In Patients With Recurrent Small-cell Lung Cancer At ASCO 2018

PharmaMar Presents New Results With Lurbinectedin As A Single Agent In Patients With Recurrent Small-cell Lung Cancer At ASCO 2018

MADRID, June 4, 2018 /PRNewswire/ -- Abstract #8570 The phase II basket trial, which began recruiting 15 patients with recurrent small-cell lung cancer, was increased to target enrolment of 100 after obtaining a positive response.

PulteGroup Becomes #98 Most Shorted S&P 500 Component, Replacing Mylan

The most recent short interest data has been released for the 05/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Jim Cramer: Homebuilder, Consumer Packaged Goods Stocks Face the 'New' Bad

Jim Cramer: Homebuilder, Consumer Packaged Goods Stocks Face the 'New' Bad

These stocks are like spewing volcanoes. You do not want to get hit by one of them.

PulteGroup Announces Quarterly Cash Dividend Of $0.09 Per Share

PulteGroup Announces Quarterly Cash Dividend Of $0.09 Per Share

PulteGroup, Inc. (NYSE: PHM) announced today that its Board of Directors has declared a quarterly cash dividend of $0.

IIROC Trading Resumption - PHM; PHM.DB

Novice Trade: PulteGroup

Novice Trade: PulteGroup

A PHM bullishly biased, out-of-the-money vertical call spread expiring in July.

IIROC Trading Halt - PHM.DB

PulteGroup's Presentation At The J.P. Morgan Homebuilding & Building Products Conference To Be Webcast Live

PulteGroup's Presentation At The J.P. Morgan Homebuilding & Building Products Conference To Be Webcast Live

PulteGroup, Inc. (NYSE: PHM), will present at the J.

TheStreet Quant Rating: B+ (Buy)